Page 54 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 1 The Etiology of Cancer 33

306. Rojko JL, Hardy Jr WD: Feline leukemia virus and other retrovi- 330. Jarrett O, Hardy Jr WD, Golder MC, et al.: The frequency of
ruses. In Sherding RG, editor: The cat: diseases and clinical manage- occurrence of feline leukaemia virus subgroups in cats, Int J Cancer
ment, 2nd ed? New York, 1994, Churchill Livingstone, pp 263–432. 21:334–337, 1978.
VetBooks.ir 307. Cotter SM: Feline viral neoplasia. In Greene CE, editor: Infectious 331. Jarrett O, Russell PH: Differential growth and transmission in
cats of feline leukaemia viruses of subgroups A and B, Int J Cancer
diseases of the dog and cat, 2nd ed? Philadelphia, 1998, WB Saunders.
21:466–472, 1978.
308. Hardy Jr WD, Hess PW, MacEwen EG, et al.: Biology of feline
leukemia virus in the natural environment, Cancer Res 36:582– 332. Rosenberg Z, Pederson ZF, Haseltine WA: Comparative analysis of
588, 1976. the genome of feline leukemia virus, J Virol 35:542–546, 1980.
309. Essex M: Feline leukemia and sarcoma viruses. In Klein G, editor: 333. Tzavaras T, Stewart M, McDougall A, et al.: Molecular cloning and
Viral oncology, New York, 1980, Raven Press. characterization of a defective recombinant feline leukaemia virus
310. Hardy Jr WD: The feline leukemia virus, J Am Anim Hosp Assoc associated with myeloid leukaemia, J Gen Virol 71:343–354, 1990.
17:951, 1981. 334. Stewart MA, Warnock M, Wheeler A, et al.: Nucleotide sequences
311. Pedersen NC: Feline immunodeficiency virus. In Schellekens LT, of a feline leukemia virus subgroup: a envelope gene and long ter-
Horzinek MC, editors: Animal models in AIDS, Amsterdam, 1990, minal repeat and evidence for the recombinational origin of sub-
Elsevier. group B viruses, J Virol 58:825–834, 1986.
312. Hardy Jr WD: The feline sarcoma viruses, J Am Anim Hosp Assoc 335. Elder JM, Mullins JI: Nucleotide sequence of the envelope gene of
17:981, 1981. Gardner-Arnstein feline leukemia virus B reveals unique sequence
313. Benveniste RE, Sherr CJ, Todaro GJ: Evolution of type C viral homologies with a murine mink cell focus-forming virus, J Virol
genes: origin of feline leukemia virus, Science 190:886–888, 1975. 46:871–880, 1983.
314. Daniels MJ, Golder MC, Jarrett O, et al.: Feline viruses in wildcats 336. Rigby MA, Rojko JL, Stewart MA, et al.: Partial dissociation of sub-
from Scotland, J Wildl Dis 35:121–124, 1999. group C phenotype and in vivo behaviour in feline leukaemia viruses
315. Marker L, Munson L, Basson PA, et al.: Multicentric T-cell lymphoma with chimeric envelope genes, J Gen Virol 73:2839–2847, 1992.
associated with feline leukemia virus infection in a captive Namibian 337. Heding LD, Schaller JP, Blakeslee JR, et al.: Inactivation of tumor
cheetah (Acinonyx jubatus), J Wildl Dis 39:690–695, 2003. cell–associated feline oncornavirus for preparation of an infectious
316. Schafer W, Bolognesi DP: Mammalian type C oncornaviruses: virus–free tumor cell immunogen, Cancer Res 36:1647–1652, 1976.
relationships between viral structure and cell surface antigens and 338. Essex M, Klein G, Snyder SP, et al.: Correlation between humoral
their possible significance in immunological defense mechanisms, antibody and regression of tumours induced by feline sarcoma
Contemp Top Immunobiol 6:127–167, 1977. virus, Nature 233:195–196, 1971.
317. Bolognesi DP, Montelaro RC, Frank H, et al.: Assembly of type C 339. Vedbrat S, Rasheed S, Lutz H, et al.: Feline oncornavirus–associated
oncornaviruses: a model, Science 199:183–186, 1978. cell membrane antigen: a viral and not a cellularly coded transfor-
318. Hardy Jr WD: Immunology of oncornaviruses, Vet Clin North Am mation-specific antigen of cat lymphomas, Virology 124:445–461,
4:133–146, 1974. 1983.
319. Sarma PS, Log T: Subgroup classification of feline leukemia and 340. Snyder HW, Singhal MC, Zuckerman EE, et al.: The feline oncor-
sarcoma viruses by viral interference and neutralization tests, Virol- navirus associated cell membrane antigen (FOCMA) is related to,
ogy 54:160–169, 1973. but distinguishable from, FeLV-C gp70, Virology 131:315–327,
320. Sarma PS, Log T, Jain D, et al.: Differential host range of viruses of 1983.
feline leukemia-sarcoma complex, Virology 64:438–446, 1975. 341. Macy DW: Vaccination against feline retroviruses. In August J, edi-
321. Hardy WD Jr, Hirshaut Y, Hess P: Detection of the feline leu- tor: Consultations in feline internal medicine, Philadelphia, 1994,
kemia virus and other mammalian oncornaviruses by immuno- WB Saunders, pp 33–39.
fluorescence. In Dutcher RM, Chieco-Bianchi L, editors: Unifying 342. Dorn CR, Taylor DON, Schneider R, et al.: Survey of animal neo-
concepts of leukemia, Basel: S Karger, 1973, pp 833–841. plasms in Alameda and Contra Costa counties, California. II. Can-
322. Francis DP, Essex M, Gayzagian D: Feline leukemia virus: survival cer morbidity in dogs and cats from Alameda county, J Natl Cancer
under home and laboratory conditions, J Clin Microbiol 9:154– Inst 40:307–318, 1968.
156, 1979. 343. Schneider R: Comparison and age- and sex-specific incidence rate
323. Dornsife RE, Gasper PW, Mullins JI: Induction of aplastic anemia patterns of the leukemia complex in the cat and the dog, J Natl
by intrabone marrow inoculation of a molecularly cloned feline ret- Cancer Inst 70:971–977, 1983.
rovirus, Leuk Res 13:745–755, 1989. 344. Goitsuka R, Tsuji M, Matsumoto Y, et al.: A case of feline large
324. Hartmann K, Werner RM, Egberink H, et al.: Comparison of six granular lymphoma, Jpn J Vet Sci 50:593–595, 1988.
in-house tests for the rapid diagnosis of feline immunodeficiency 345. Finn JP, Schwartz LW: A neoplasm of globule leukocytes in the
and feline leukaemia virus infections, Vet Rec 149:317–320, 2001. intestine of a cat, J Comp Pathol 82:323–326, 1972.
325. Lauring AS, Anderson MM, Overbaugh J: Specificity in receptor 346. Hardy Jr WD, McClelland AJ, Zuckerman EE, et al.: Develop-
usage by T-cell–tropic feline leukemia viruses: implications for the ment of virus non-producer lymphosarcomas in pet cats exposed to
in vivo tropism of immunodeficiency-inducing variants, J Virol FeLV, Nature 288:90–92, 1980.
75:8888–8898, 2001. 347. Hardy Jr WD, Zuckerman EE, McClelland AJ, et al.: The immu-
326. Lauring AS, Cheng HH, Eiden MV, et al.: Genetic and biochemi- nology and epidemiology of FeLV-nonproducer feline lymphosar-
cal analyses of receptor and cofactor determinants for T-cell–tropic comas, Cold Spring Harbor Conf Cell Prolif 7:677, 1980.
feline leukemia virus infection, J Virol 76:8069–8078, 2002. 348. Hardy Jr WD: Hematopoietic tumors of cats, J Am Anim Hosp
327. Essex M, Cotter SM, Sliski AH, et al.: Horizontal transmission Assoc 17:921–940, 1981.
of feline leukaemia under natural conditions in a feline leukaemia 349. Spodnick GJ, Berg J, Moore FM, et al.: Spinal lymphoma in cats:
cluster household, Int J Cancer 19:90–96, 1977. 21 cases (1976-1989), J Am Vet Med Assoc 200:373–376, 1992.
328. Vail DM, Moore AS, Ogilvie GK, et al.: Feline lymphoma (145 350. Hartmann K, Gerle K, Leutenegger C, et al.: Feline leukemia virus:
cases): proliferation indices, CD3 immunoreactivity and their asso- most important oncogene in cats? Abstracts from the Fourth Interna-
ciation with prognosis in 90 cats receiving therapy, J Vet Intern Med tional Feline Retrovirus Research Symposium, 1998. Glasgow.
12:349–354, 1998. 351. Teske E, van Straten G, van Noort R, et al.: Chemotherapy with
329. Louwerens M, London CA, Pedersen NC, et al.: Feline lymphoma cyclophosphamide, vincristine, and prednisolone (COP) in cats
in the post-feline leukemia virus era, J Vet Intern Med 19:329–335, with malignant lymphoma: new results with an old protocol, J Vet
2005. Intern Med 16:179–186, 2002.